These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

828 related articles for article (PubMed ID: 33913533)

  • 1. Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
    Lee J; Song JU
    J Med Virol; 2021 Jul; 93(7):4523-4531. PubMed ID: 33913533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance of Abbott ID Now COVID-19 Rapid Nucleic Acid Amplification Test Using Nasopharyngeal Swabs Transported in Viral Transport Media and Dry Nasal Swabs in a New York City Academic Institution.
    Basu A; Zinger T; Inglima K; Woo KM; Atie O; Yurasits L; See B; Aguero-Rosenfeld ME
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32471894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Adriano A; Berhane S; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2020 Aug; 8(8):CD013705. PubMed ID: 32845525
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid, point-of-care antigen and molecular-based tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Deeks JJ; Berhane S; Taylor M; Adriano A; Davenport C; Dittrich S; Emperador D; Takwoingi Y; Cunningham J; Beese S; Domen J; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Taylor-Phillips S; Hooft L; Leeflang MM; McInnes MD; Spijker R; Van den Bruel A;
    Cochrane Database Syst Rev; 2021 Mar; 3(3):CD013705. PubMed ID: 33760236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-Point Mutations in the N Gene of SARS-CoV-2 Adversely Impact Detection by a Commercial Dual Target Diagnostic Assay.
    Miller S; Lee T; Merritt A; Pryce T; Levy A; Speers D
    Microbiol Spectr; 2021 Dec; 9(3):e0149421. PubMed ID: 34787486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of abbott ID NOW COVID-19 rapid molecular assay to cepheid xpert xpress SARS-CoV-2 assay in dry nasal swabs.
    Serei VD; Cristelli R; Joho K; Salaru G; Kirn T; Carayannopoulous MO; Uprety P
    Diagn Microbiol Infect Dis; 2021 Apr; 99(4):115208. PubMed ID: 33545455
    [No Abstract]   [Full Text] [Related]  

  • 7. Point-of-care testing for the detection of SARS-CoV-2: a systematic review and meta-analysis.
    Yoon SH; Yang S; Cho H; Eun S; Koo CM; Kim MK
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):503-517. PubMed ID: 33506942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performances of the VitaPCR™ SARS-CoV-2 Assay during the second wave of the COVID-19 epidemic in France.
    Fitoussi F; Dupont R; Tonen-Wolyec S; Bélec L
    J Med Virol; 2021 Jul; 93(7):4351-4357. PubMed ID: 33738829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay.
    Khoshchehreh M; Wald-Dickler N; Holtom P; Butler-Wu SM
    J Clin Virol; 2020 Dec; 133():104683. PubMed ID: 33142250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample pooling on the Cepheid Xpert® Xpress SARS-CoV-2 assay.
    Graham M; Williams E; Isles N; Buadromo E; Toatu T; Druce J; Catton M; Lin C; Howden BP; Williamson DA
    Diagn Microbiol Infect Dis; 2021 Feb; 99(2):115238. PubMed ID: 33171384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV Test.
    Mostafa HH; Carroll KC; Hicken R; Berry GJ; Manji R; Smith E; Rakeman JL; Fowler RC; Leelawong M; Butler-Wu SM; Quintero D; Umali-Wilcox M; Kwiatkowski RW; Persing DH; Weir F; Loeffelholz MJ
    J Clin Microbiol; 2021 Feb; 59(3):. PubMed ID: 33298613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of SARS-CoV-2 by Use of the Cepheid Xpert Xpress SARS-CoV-2 and Roche cobas SARS-CoV-2 Assays.
    Moran A; Beavis KG; Matushek SM; Ciaglia C; Francois N; Tesic V; Love N
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32303565
    [No Abstract]   [Full Text] [Related]  

  • 13. Multi-center evaluation of cepheid xpert® xpress SARS-CoV-2 point-of-care test during the SARS-CoV-2 pandemic.
    Wolters F; van de Bovenkamp J; van den Bosch B; van den Brink S; Broeders M; Chung NH; Favié B; Goderski G; Kuijpers J; Overdevest I; Rahamat-Langedoen J; Wijsman L; Melchers WJ; Meijer A
    J Clin Virol; 2020 Jul; 128():104426. PubMed ID: 32417674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical Evaluation of Three Sample-to-Answer Platforms for Detection of SARS-CoV-2.
    Zhen W; Smith E; Manji R; Schron D; Berry GJ
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32332061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Colorimetric reverse transcription loop-mediated isothermal amplification (RT-LAMP) as a visual diagnostic platform for the detection of the emerging coronavirus SARS-CoV-2.
    Nawattanapaiboon K; Pasomsub E; Prombun P; Wongbunmak A; Jenjitwanich A; Mahasupachai P; Vetcho P; Chayrach C; Manatjaroenlap N; Samphaongern C; Watthanachockchai T; Leedorkmai P; Manopwisedjaroen S; Akkarawongsapat R; Thitithanyanont A; Phanchana M; Panbangred W; Chauvatcharin S; Srikhirin T
    Analyst; 2021 Jan; 146(2):471-477. PubMed ID: 33165486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of a nucleocapsid protein antigen rapid test in the diagnosis of SARS-CoV-2 infection.
    Diao B; Wen K; Zhang J; Chen J; Han C; Chen Y; Wang S; Deng G; Zhou H; Wu Y
    Clin Microbiol Infect; 2021 Feb; 27(2):289.e1-289.e4. PubMed ID: 33031947
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and comparison of novel multiple cross displacement amplification (MCDA) assays with other nucleic acid amplification methods for SARS-CoV-2 detection.
    Luu LDW; Payne M; Zhang X; Luo L; Lan R
    Sci Rep; 2021 Jan; 11(1):1873. PubMed ID: 33479389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2 Test.
    Loeffelholz MJ; Alland D; Butler-Wu SM; Pandey U; Perno CF; Nava A; Carroll KC; Mostafa H; Davies E; McEwan A; Rakeman JL; Fowler RC; Pawlotsky JM; Fourati S; Banik S; Banada PP; Swaminathan S; Chakravorty S; Kwiatkowski RW; Chu VC; Kop J; Gaur R; Sin MLY; Nguyen D; Singh S; Zhang N; Persing DH
    J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32366669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of Cepheid Xpert Xpress and Abbott ID Now to Roche cobas for the Rapid Detection of SARS-CoV-2.
    Smithgall MC; Scherberkova I; Whittier S; Green DA
    J Clin Virol; 2020 Jul; 128():104428. PubMed ID: 32434706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracheal Aspirate and Bronchoalveolar Lavage as Potential Specimen Types for COVID-19 Testing Using the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV.
    Kim SH; AlMutawa F
    Microbiol Spectr; 2022 Jun; 10(3):e0039922. PubMed ID: 35583359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.